14.03.2019 • NewsAzelisDede Willams

Azelis Buys Canadian Distributor Chemroy

Azelis Buys Canadian Distributor Chemroy
Azelis Buys Canadian Distributor Chemroy

Belgium-headquartered chemicals distributor Azelis has acquired 100% of Canadian distributor Chemroy, strengthening its presence in North America’s northernmost country.

With the buy, Azelis said it is gaining a foothold as one of Canada's leading specialty distributors with a strong position in the CASE (coatings, adhesives, construction and ink), food, pharmaceutical, nutraceutical and personal care market segments.

Chemroy is complementary to Azelis in terms of markets served, principal relationships and product offering, the European distributor said, adding that it has well established relationships with the majority of the Canadian company’s principals.

Founded in 1967, the Canadian distributor has its headquarters in Brampton, Ontario, and warehousing across the country, in addition to offices in Laval, Quebec, and Vancouver, British Columbia. The company employs 59 people.

Frank Bergonzi, CEO and president of Azelis Americas, called the deal an important milestone for his company in the region. This, he said, “will ensure a more robust product portfolio to our customers."

The North American buy is the third takeover announced by Azelis this year. In January, the company said it had agreed to buy Euroconsultant, a Polish distributor of flavors, shelf-life extenders and other products. In March, it revealed the acquisition of MK Ingredients & Specialties and its subsidiary SSD, an Indian distributor active in the food and health market.

Financial terms were not disclosed for any of the transactions. Azelis belongs to private equity investors EQT VIII and PSP Investments.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.